Glaxo halts production of zinc-containing denture cream after reports of health effects
By APThursday, February 18, 2010
Glaxo to remove zinc from denture cream
WASHINGTON — GlaxoSmithKline says it will remove zinc from its denture cream, following reports that excessive use has caused neurological damage and blood problems in consumers.
The British manufacture will cease manufacturing and marketing Super Poligrip Original, Ultra Fresh and Extra Care products in the U.S. The company plans to reformulate the creams without zinc.
Glaxo’s voluntary action follows dozens of lawsuits filed against the company alleging Poligrip caused nerve damage, resulting in symptoms such as weakness and numbness, as well as blood problems like anemia.
The company says its products are safe when used as directed, but some consumers use the cream excessively to help make their dentures fit.
